A review on bispecific antibody (blinatumomab) for the treatment of acute lymphoblastic leukemia

A review on bispecific antibody (blinatumomab) for the treatment of acute lymphoblastic leukemia

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2024.

Bibliographic Details
Main Author: Choki, Kinley
Other Authors: Chowdhury, Namara Mariam
Format: Thesis
Language:English
Published: Brac University 2024
Subjects:
Acute lymphoblastic leukemia
Leukemia
R/R B-cell precursor ALL
FDA
Blood cancer
Lymphoblastic leukemia.
Cancer > Immunotherapy.
Monoclonal antibodies > Therapeutic use.
Online Access:http://hdl.handle.net/10361/24298

Internet

http://hdl.handle.net/10361/24298

Similar Items